Register Cart 0

Generic placeholder image

Current HIV Research

Editor-in-Chief

ISSN (Print): 1570-162X
ISSN (Online): 1873-4251

Back Subscribe

HIV and Substance Abuse: A Commentary

Author(s): David Shurtleff and Diane Lawrence

Volume 10, Issue 5, 2012

Page: [366 - 368] Pages: 3

DOI: 10.2174/157016212802138760

Price: $65

Keywords: HIV, Substance abuse, HAND, antiretroviral therapy (ART), gp120, neuron, methamphetamine, cocaine, opioid receptors, CXCR4, antiretroviral therapy, (ART).

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

8

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Erratum
Current Alzheimer Research

Immunopharmacology of the Main Herbal Supplements: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets

Disrupting Self-Assembly and Toxicity of Amyloidogenic Protein Oligomers by “ Molecular Tweezers” - from the Test Tube to Animal Models
Current Pharmaceutical Design

Phosphodiesterase-4 Modulation as a Potential Therapeutic for Cognitive Loss in Pathological and Non-Pathological Aging: Possibilities and Pitfalls
Current Pharmaceutical Design

Alpha-1-Antichymotrypsin: A Common Player for Type 2 Diabetes and Alzheimer's Disease
Current Diabetes Reviews

Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies
Medicinal Chemistry

Effects of Transition Metals in the Conversion Mechanism of Prion Protein and in the Pathogenesis of Prion Diseases
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents

DLPF Targeted Repetitive Transcranial Magnetic Stimulation Improves Brain Glucose Metabolism Along with the Clinical and Electrophysiological Parameters in CBD Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets

Tau in Alzheimer Disease and Related Tauopathies
Current Alzheimer Research

Fabry Disease and Cardiovascular Involvement
Current Pharmaceutical Design

Stroke in Women
Recent Patents on Cardiovascular Drug Discovery

Adrenergic Drugs Blockers or Enhancers for Cognitive Decline ? What to Choose for Alzheimer’s Disease Patients?
CNS & Neurological Disorders - Drug Targets

The Safety, Tolerability, Pharmacokinetics and Cognitive Effects of GSK239512, a Selective Histamine H<sub>3</sub> Receptor Antagonist in Patients with Mild to Moderate Alzheimer’s Disease: A Preliminary Investigation
Current Alzheimer Research

CGRP-Receptor Antagonism in Migraine Treatment
CNS & Neurological Disorders - Drug Targets

Management of Hypertension-Journey from Single Drug Therapy to Multitargeted Ligand Therapy: A Clinical Overview
Current Clinical Pharmacology

Pharmacotherapy of Sickle Cell Disease in Children
Current Pharmaceutical Design

Severe Mental Disorders from a Cognitive-Behavioural Perspective: A Comprehensive Review from Conceptualization to Intervention
Current Psychiatry Reviews

The State of the Problem of Achieving Extremely Low LDL Levels
Current Pharmaceutical Design

Tuberculostatic Drugs Targeting Infections of the Central Nervous System
Anti-Infective Agents

A Neurotrophic Rationale for the Therapy of Neurodegenerative Disorders
Current Alzheimer Research

© 2025 Bentham Science Publishers | Privacy Policy